 BEDMER, N.J.--BUSINESS WIRE--TYME Technologies, Inc. Nasdaq: TYME the Company or TYME, an emerging biotechnology company developing cancer metabolism-based therapies CMBTsTM, today announced that Richie Cunningham, Chief Executive Officer, and Frank Porfido, Chief Financial Officer, will present virtually at two upcoming healthcare conferences as follows: H.C. Wainwright 23rd Annual Global Investment Conference Date: Monday, September 13, 2021 Time: On demand beginning at 7:00a 